|
Cardiovascular risk factors at baseline and follow-up in patients with the metabolic syndrome1 |
||||||||||
| Baseline |
8 weeks |
Difference2 |
||||||||
| N |
mean |
± SD |
N |
mean |
± SD |
N |
mean |
± SD |
||
|
|
||||||||||
| Blood pressure |
||||||||||
| systolic |
mmHg |
1319 |
160.0 |
13.8 |
1312 |
133.3 |
10.4 |
1289 |
-26.6* |
14.3 |
| diastolic |
mmHg |
1319 |
94.6 |
8.6 |
1312 |
80.9 |
6.5 |
1289 |
-13.6* |
9.2 |
|
|
||||||||||
| Fasting plasma glucose |
||||||||||
| mg/dL |
1234 |
95.5 |
17.9 |
769 |
92.9 |
14.9 |
764 |
-2.5* |
13.1 |
|
|
|
||||||||||
| Waist circumference |
||||||||||
| men |
cm |
634 |
107.2 |
11.7 |
599 |
106.1 |
11.8 |
598 |
-1.1* |
4.1 |
| women |
cm |
530 |
97.3 |
13.0 |
498 |
96.7 |
13.3 |
496 |
-0.7* |
3.5 |
|
|
||||||||||
| Triglycerides |
||||||||||
| mg/dL |
1186 |
205.0 |
91.3 |
753 |
185.0 |
74.4 |
741 |
-19.1* |
61.0 |
|
|
|
||||||||||
| HDL Cholesterol |
||||||||||
| men |
mg/dL |
635 |
46.9 |
17.4 |
395 |
47.6 |
13.3 |
384 |
1.1* |
11.0 |
|
|
||||||||||
| women |
mg/dL |
526 |
51.3 |
16.6 |
338 |
53.2 |
15.6 |
331 |
2.3* |
10.8 |
|
1 defined by the AHA/NHLBI 2004 [17]; 2 difference versus baseline; statistical test applied: t-test; * p < 0.0001. Adjusted for age. | ||||||||||
Bramlage et al. BMC Cardiovascular Disorders 2008 8:30 doi:10.1186/1471-2261-8-30 |
||||||||||